Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AAA, addressed, Alan, arbitration, arbitrator, attorney, Black, borne, calendar, card, cure, debit, delist, delisting, Delta, diem, discharge, Dispute, disputed, duty, family, fiduciary, forum, harbor, hearing, hypothetical, inactive, instance, Internet, labor, lifting, noteholder, notifying, Omicron, omitted, outlook, paper, peptide, placement, plaintiff, proxy, Reform, regain, sound, SRA, tabulation, textual, therefrom, treasury, unforeseeable, unrealized, uplisting, Urban, venue, waiting, website, worse
Filing tables
Filing exhibits
GTBP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File Nos. 333-255429, 333-252973 and 333-251311), Form S-8 (File No. 333-266316) and Form S-3 (File No. 333-267870) of GT Biopharma, Inc. of our report dated March 30, 2023 relating to the consolidated financial statements of GT Biopharma, Inc. as of December 31, 2022 and 2021, and for the year then ended which appears in this Form 10-K.
Weinberg & Company, P.A.
Los Angeles, California
March 30, 2023